Storage conditions and storage precautions for Tazerestat (Daveco)
Tazemetostat (Tazemetostat) is an oral small molecule targeted drug, usually provided in capsule form. In order to ensure the stability and efficacy of the drug, it is recommended to store it at room temperature below 25°C and avoid high or low temperatures. Medications should be placed in the original packaging and sealed to avoid being affected by moisture and light to ensure that the active ingredients do not degrade.
Tazemetostat is sensitive to humidity and light, and long-term exposure may affect drug stability and efficacy. It is recommended to keep the medication in a dry environment away from water, bathrooms or wet areas. Packaging usually has a moisture-proof design, but extra attention should be paid to sealed storage in high-humidity environments. At the same time, avoid direct sunlight or strong light to prevent the decomposition of drug ingredients or color change.

Special attention should be paid to the safety of children and pets when storing tazerestat. Medications should be placed high up or in a locked cabinet to prevent accidental ingestion. Mistaken use may cause serious adverse reactions, especially in children or pets who are underweight. Therefore, drug management is not only a requirement to ensure efficacy, but also an important part of drug safety.
When transporting medicines or traveling, avoid high temperatures, strong light, and long-term shaking to prevent capsule damage or reduced efficacy. Once the drug expires or the packaging is damaged, it should be disposed of immediately according to the doctor's instructions or pharmacy instructions, and no further use should be allowed. Proper storage and proper management of tazetostat can help maintain drug efficacy while ensuring patient safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)